A rare “blood moon” lunar eclipse was fully visible over Hawaiʻi on March 3, 2026, and guests at the Hyatt Regency Maui Resort and Spa had a front-row seat. The resort hosted a special viewing under ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Ever wondered how your favourite apps seem to chat with each other? Or how you can book a taxi, check the weather, and post to social media all from your phone? The secret sauce is often something ...

The NASA Mars Sample Return program is encountering resistance from the planetary science community due to proposed budget language that would terminate the current mission framework. In early January ...

Learn how to use advanced techniques like short-circuiting, parallel execution, virtual threads, and stream gatherers to maximize Java stream performance. My recent Java Stream API tutorial introduced ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive ...

The Constellation-class frigate will now go the same way as the Zumwalt-class destroyer and the Littoral Combat Ship—expensive programs canceled well before their time, at great cost to the taxpayer.

The Reactor Pilot Program has its pros, but it needs to be paired with money and action from Congress and the presidency. Last month, the US Department of Energy (DOE) announced the selection of ten ...

When running a Java program in Eclipse IDE that uses Scanner.nextLine() for user input, the console fails to reposition the input cursor correctly after an exception or invalid input. Even though the ...

The code generated by large language models (LLMs) has improved some over time — with more modern LLMs producing code that has a greater chance of compiling — but at the same time, it's stagnating in ...

First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...